Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Ruggero Losappio"'
2
Akademický článek
Real life rates of sustained virological response (SVR) and predictors of relapse following DAA treatment in genotype 3 (GT3) patients with advanced fibrosis/cirrhosis.
Autor: Alessandra Mangia, Ruggero Losappio, Giovanni Cenderello, Domenico Potenza, Michele Mazzola, Giulio De Stefano, Natalia Terreni, Massimiliano Copetti, Nicola Minerva, Valeria Piazzola, Donato Bacca, Vincenzo Palmieri, Fernando Sogari, Rosanna Santoro
Publikováno v: PLoS ONE, Vol 13, Iss 7, p e0200568 (2018)
BACKGROUND:Treatment of GT3 remains challenging compared to other genotypes. AIMS:To explore real life SVR rates and to identify predictors of virological failure across the most recently used Direct acting antiviral (DAA) regimens in a large cohort
Externí odkaz: https://doaj.org/article/9ffa29c54a8f4cdfb2cee082cbfb388f
Zobrazit plný text záznamu
5
Ribavirin and boceprevir are able to reduce Canine distemper virus growth in vitro
Autor: Michele Camero, Ruggero Losappio, Gianvito Lanave, Nicola Decaro, Tommaso Fontana, Vito Martella, Domenico Buonavoglia, Maria Tempesta, Alessandra Cavalli
Publikováno v: Journal of Virological Methods. 248:207-211
Canine distemper virus (CDV) is a major infectious disease of dogs. Although vaccines were successful to control CDV spread in canine population, the disease is still common and may pose a threat to unvaccinated dogs. In the attempt to develop specif
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b1f3f9e176561311ba9908795b1e250
https://doi.org/10.1016/j.jviromet.2017.07.012
Zobrazit plný text záznamu
6
Sofosbuvir and ribavirin for genotype 2 HCV infected patients with cirrhosis: A real life experience
Autor: Christoph Sarrazin, Valeria Piazzolla, Immacolata Carraturo, Vincenzo Palmieri, Domenico Potenza, Maria Miscio, Ernesto Agostinacchio, Massimiliano Copetti, Simone Susser, Rosanna Santoro, Giancarlo Spinzi, Ruggero Losappio, Alessandra Mangia, Giulio De Stefano, Andrea Arleo
Publikováno v: Journal of Hepatology. 66:711-717
Background & Aims Sofosbuvir (SOF) and weight-based ribarivin (RBV) represented until recently the standard of care in hepatitis C virus (HCV) genotype (GT)2 patients. In registration studies 12–16weeks duration were associated with a 90% sustained
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fbc565348a225781ffe3ab408c61f97
https://doi.org/10.1016/j.jhep.2016.12.002
Zobrazit plný text záznamu
7
Real life rates of sustained virological response (SVR) and predictors of relapse following DAA treatment in genotype 3 (GT3) patients with advanced fibrosis/cirrhosis
Autor: Natalia Terreni, Massimiliano Copetti, Ruggero Losappio, Vincenzo Palmieri, Domenico Potenza, Giovanni Cenderello, D. Bacca, Giulio De Stefano, Alessandra Mangia, Rosanna Santoro, Fernando Sogari, Michele Mazzola, Nicola Minerva, Valeria Piazzola
Publikováno v: PLoS ONE, Vol 13, Iss 7, p e0200568 (2018)
PLoS ONE
Background Treatment of GT3 remains challenging compared to other genotypes. Aims To explore real life SVR rates and to identify predictors of virological failure across the most recently used Direct acting antiviral (DAA) regimens in a large cohort
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a0f05693102060d62294d7e5b08e596
http://europepmc.org/articles/PMC6067691?pdf=render
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje